跳至主要内容
临床试验/NL-OMON35858
NL-OMON35858已完成不适用

Pharmacology of rapid-acting insulin injected by needle-free jet-injection in patients with diabetes - Insulin administration by jet injection

niversitair Medisch Centrum Sint Radboud0 个研究点目标入组 24 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
24

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Age 18-70 years
  • Body-mass index 18-30 kg/m2
  • Stable glycaemic control with HbA1c 6.5-9.0%
  • Duration of diabetes >1 year
  • Insulin use at least once daily or with subcutaneous pump
  • Blood pressure <160/90 mmHg

排除标准

  • Inability to provide informed consent
  • Requirement of <8 units of rapid-acting insulin (analogue) before meals
  • Chronic use of anticoagulants
  • Chronic use of sulphonylurea derivatives, GLP-1 based treatments, acarbose or thiazolidinediones
  • Chronic use of three or more blood pressure lowering agents (except thiazide diuretics)
  • Treatment with prednisolone, non-steriodal anti-inflammatory drugs (NSAIDs), immunosuppressive agents, cytostatic drugs, hormone therapy except insulin, thyroid supplementation and oral anticonceptives
  • Known allergy to aspart insulin
  • Macroalbuminuria, i.e. urinary albumin excretion >200 *g/min in collected urine sample or urinary albumin-to-creatinine ratio >300 mg/g in spot urine sample
  • Symptomatic diabetic neuropathy
  • Proliferative diabetic retinopathy (a history of proliferative retinopathy that was successfully treated with laser coagulopathy is not an exclusion criterion)
  • History of a major cardiovascular disease event (myocardial infarction, stroke, symptomatic peripheral artery disease, coronary bypass surgery, percutaneous coronary or peripheral artery angioplasty)
  • Pregnancy or the intention to become pregnant

研究者

发起方
niversitair Medisch Centrum Sint Radboud

相似试验